SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000078003-22-000018
Filing Date
2022-02-14
Accepted
2022-02-11 18:06:57
Documents
2
Group Members
PF EQUITY HOLDINGS 4 B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A 3 CORTEXYME cortexyme_13gax3x2x22f.htm SC 13G/A 68345
2 EX-99.1 JOINT FILING AGREEMENT cortexyme_sc13ga1xexhx99x1.htm EX-99.1 7004
  Complete submission text file 0000078003-22-000018.txt   76994
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filed by) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Subject) CIK: 0001662774 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91007 | Film No.: 22623350
SIC: 2836 Biological Products, (No Diagnostic Substances)